Johnson & Johnson
JNJ
#20
Rank
HK$4.277 T
Marketcap
HK$1,775
Share price
-0.02%
Change (1 day)
52.65%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2025 (TTM): HK$718.24 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is HK$719.93 Billion. In 2024 the company made a revenue of HK$689.56 Billion an increase over the revenue in the year 2023 that were of HK$665.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$718.24 B4.16%
2024 HK$689.56 B3.68%
2023 HK$665.09 B-6.61%
2022 HK$712.16 B-2.61%
2021 HK$731.21 B14.22%
2020 HK$640.20 B0.18%
2019 HK$639.08 B0.04%
2018 HK$638.85 B6.96%
2017 HK$597.30 B7.14%
2016 HK$557.47 B2.64%
2015 HK$543.12 B-5.8%
2014 HK$576.54 B4.26%
2013 HK$552.97 B6.12%
2012 HK$521.06 B3.16%
2011 HK$505.08 B5.38%
2010 HK$479.28 B-0.14%
2009 HK$479.93 B-2.57%
2008 HK$492.60 B3.41%
2007 HK$476.35 B14.86%
2006 HK$414.72 B5.89%
2005 HK$391.65 B6.44%
2004 HK$367.95 B13.4%
2003 HK$324.48 B14.63%
2002 HK$283.06 B11.72%
2001 HK$253.38 B10%
2000 HK$230.35 B6.57%
1999 HK$216.16 B17.94%
1998 HK$183.28 B4.52%
1997 HK$175.36 B4.87%
1996 HK$167.22 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
HK$440.41 B-38.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$490.52 B-31.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$342.53 B-52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$271.55 B-62.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$464.22 B-35.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$371.29 B-48.43%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
HK$227.24 B-68.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
HK$190.48 B-73.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$501.84 B-30.29%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$330.88 B-54.04%๐Ÿ‡ฌ๐Ÿ‡ง UK